Secondary Prevention for Ischemic Heart Disease

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

1992 • 5,885 citations

Clinical Epidemiology: A Basic Science for Clinical Medicine.

1991 • 3,572 citations

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

1994 • 3,408 citations

EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)

1989 • 2,639 citations

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1996 • 2,163 citations

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

1994 • 2,133 citations

An Assessment of Clinically Useful Measures of the Consequences of Treatment

1988 • 1,650 citations

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia

1990 • 999 citations

The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction

1990 • 651 citations

Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)

1990 • 613 citations

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1989 • 513 citations

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris

1992 • 509 citations

Preventing heart attack and death in patients with coronary disease

1995 • 314 citations

Aspirin in coronary heart disease

1976 • 311 citations

Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin

1986 • 254 citations

Cholesterol Lowering and the Use of Healthcare Resources

1996 • 194 citations

Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction

1981 • 188 citations

The FDA's Critique of the Anturane Reinfarction Trial

1980 • 149 citations

The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.

1980 • 101 citations

Exercise after myocardial infarction: a controlled trial.

1982 • 82 citations

Reduction in sudden deaths and coronary mortality in myocardial infarction patients after rehabilitation

1995 • 71 citations

The Lopressor Intervention Trial: Multicentre study of metoprolol in survivors of acute myocardial infarction

1987 • 67 citations

Program on the surgical control of the hyperlipidemias (POSCH): Design and methodology

1989 • 43 citations

Management of the postmyocardial infarction patient: a consensus report--revision of 1991 CCS guidelines.

1995 • 32 citations

Program on the surgical control of the hyperlipidemias (POSCH): Patient entry characteristics

1991 • 16 citations